Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study | MicrobiomeTrials← Back to trialsNCT06230887
Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study
ENROLLING_BY_INVITATIONNAINTERVENTIONAL
Trial Details
Start: 2024-07-30Est. Completion: 2028-01-01
Enrollment target: 200 participants Locations- Central Arkansas Veterans Healthcare System , Little Rock, AR, Little Rock, Arkansas, United States
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur, Georgia, United States
- Maine VA Medical Center, Augusta, ME, Augusta, Maine, United States
- Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis, Minnesota, United States
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston, Texas, United States
Other microbiome trials you might be interested in
Failed Back Surgery Syndrome
Introduction. At the neurophysiological level, it is possible to observe an increase in the central processing of pain i…
Torrent, SpainCompleted Jan 1, 2026
Heart FailureMyocardial Infarction
Multicenter Prospective Controlled Randomized Trial, open-label, in patients with atherosclerotic cardiovascular disease…
Leuven, BelgiumEst. completion Jun 30, 2027